Navigation Links
Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
Date:2/15/2013

San Diego, CA (PRWEB) February 15, 2013

Nasseo, Inc., a medical device company based in San Diego, CA, is pleased to announce that it has closed its $520K seed financing round. BioInspire™, a medical technology incubator that funded Nasseo earlier this year, leads the round along with an internationally renowned dentist. The Nasseo TiArray™ dental implant system, the first product based on Nasseo’s proprietary implant surface modification technology, has been developed for diabetics and smokers with poor bone healing who are seeking dental implants but have limited treatment options with today’s technology. Nasseo offers dentists cost-effective, high quality, and easy-to-use implants that significantly improve clinician productivity and expand patient care options.

BioInspire™ is a collaborative partnership between BioAccel®, Plaza Companies, and the City of Peoria, Arizona, that provides working capital and space to those companies selected and admitted per its application criteria. BioInspire™ focuses on directly addressing the challenges of commercializing medical devices by providing portfolio companies with assistance in funding, partnerships and mentorship.

Dr. Garrett Cale Smith, Co-Founder and CEO of Nasseo, says, “We are honored to be selected as a BioInspire™ portfolio company and to be identified as a medtech company that is poised for investment based upon the unmet clinical need that our enabling technology is addressing.”

Nasseo’s technology has received increasingly enthusiastic reception from members across diverse sectors of the scientific and investment community. Most recently, Nasseo participated in World’s Best Technology (WBT) Innovation Marketplace 2012, the premier showcase for life science and technology innovation. There, Nasseo was selected as part of an elite group to present its surface modification technology to venture capitalists and other attendees at the event, which is sponsored by Northrup Grumman. Kayvon Pourmirzaie, JD, Nasseo’s Co-Founder and COO, confirms, “Our inclusion in BioInspire™ is a significant milestone as it gives us access to a wealth of resources and opportunities that will support moving forward aggressively with our go-to-market strategy.”

Nasseo is joining the BioInspire™ community at the same time as it experiences internal growth with the addition of Mr. Brian Jaffe to its Board of Advisors. Mr. Jaffe has over 15 years of senior level experience in dental implants and medical devices and is currently the president of Quantive LLC, a consulting firm specializing in helping dental and medical device companies launch new products in the United States. He was previously Vice President of Sales and Marketing at Implant Direct, a leading global manufacturer of dental implants and prosthetics that was acquired by Danaher Corporation for $300M in 2010. He holds an MBA from Harvard Business School and a Masters in Science Degree in Mechanical Engineering from UC Berkeley.

Dr. Smith says, “We are joining BioInspire™ and bringing Brian in at an exciting time in Nasseo’s growth. We will continue to seek out every opportunity, internally and externally, to successfully commercialize our first product, the TiArray™ dental implant system, to reach a large and underserved group of patients.”

The company plans to raise a $3M+ Series A investment round in mid 2013 to catalyze production and sales.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in San Diego, CA. For more information, please visit our website at http://www.nasseo.com or contact us at info(at)nasseo.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10436080.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Robert Storey Joins VIC Technology Venture Development as Executive in Residence
2. Michael Berman Joins InspireMD Board
3. Rudy Mazzocchi Joins the Greatbatch Board of Directors as he Continues to Expand his Presence in the Med-tech Industry
4. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
5. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. John A. Orwin Joins Array BioPharma Board Of Directors
8. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
9. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
10. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
11. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... at the LEERINK Partners 6th Annual Global Healthcare Conference ... February 15, 2017 at 10 a.m. Eastern Time. ... be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast will ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
Breaking Biology News(10 mins):